This product is a fluoroquinolone antibiotic that has antibacterial effects on Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, etc.) and some Gram-positive cocci, and has a bactericidal effect by inhibiting bacterial DNA gyrase.

This product belongs to the quinolone antibacterial drug, which is the levorotatory form of ofloxacin. Its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial DNA gyrase and the replication of bacterial DNA. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect, and has good antibacterial effect on most Enterobacteriaceae, some Staphylococci, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Chlamydia, etc.

Quinolone antibiotics inhibit bacterial DNA gyrase activity and bacterial DNA replication, and have broad-spectrum and potent antibacterial properties. They have good antibacterial effects on Enterobacteriaceae (such as Klebsiella pneumoniae, Proteus, etc.), some Staphylococci, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Chlamydia, etc.

One of the eight essential amino acids for the human body, it combines with ATP to generate S-adenosine, promotes methylation of liver cell membrane phospholipids, reduces intrahepatic bile stasis, enhances transsulfurization, restores the physiological function of liver cells, promotes the disappearance of jaundice and recovery of liver function, supplies methyl groups to promote choline synthesis, promotes liver fat metabolism, protects the liver and detoxifies.

It combines with pyrophosphate in the body to form a cocarboxylase, participating in the oxidative decarboxylation reaction of pyruvate and a-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism.